Venture Capital

Angel investing often is the first money coming into a young company, and although it is a large segment of overall venture capital, it hasn't been tracked as closely. That's beginning to change, according to columnist Michael Rosen, and in this edition of Yer Biotech...

The judging was tough and honest, and the lessons were many as companies seeking capital made their elevator pitches to investors during the annual Wisconsin Early-Stage Symposium. The Elevator Pitch Olympics were an opportunity for start-up companies to hone their presentations and learn from investors,...

Just as Wisconsin is gaining some traction in the venture capital chase, a federal bill threatens to make the state less attractive to private-equity investors, particularly from outside Wisconsin, opines columnist Tom Still. In this edition of Inside Wisconsin, Still notes that the bill is...

A new study on angel investments cites both the risk and reward associated with such investments in start-up companies. The national study indicates that angel investors taking part in organized angel groups achieve an average 27 percent rate of return, but investors also lost their...

With regard to the recently enacted state budget, columnist Tom Still asks the $57 billion question: what does this tax-and-spend plan actually accomplish over the next two years? In this edition of Inside Wisconsin, he supplies a few answers, including renewal and expansion of the...

Three more Wisconsin technology companies have been qualified under the Act 255 angel and venture investment tax credit program. Investors who commit angel or venture capital to either Windlift, LLC, Centrose, LLC, or SymbiontWeb, Inc., will be eligible to receive the tax credits....

Investors flocked to Milwaukee this week for the BIO Mid-America VentureForum and had some promising things to say about the future of venture capital deployment in Wisconsin. Rather than dwelling on any one state or quarterly period, they recommend tracking success over the entire region...

As it approaches an all-important presentation to investment funds at the BIO Mid-America VentureForum, Madison's Centrose, LLC has received an $875,000 funding commitment from the State Department of Financial Institutions. The company, which is developing drug therapies based on proprietary sugar chemistries, is seeking a...